📢Our new paper out in @JNCI_Now Cancer Spectrum! We studied racial & ethnic differences in treatment & survival among patients with #hepatocellularcarcinoma (HCC) receiving systemic therapy.

The worst thing about residency is that it makes you a mediocre person as you have no time to do the things that made you brilliant enough to get the job.

Many thanks to @MedicalFrank, @BrandonGOConnor and Uchechukwu Uzomah, MD, for their IR Quarterly article with @SIRspecialists! The article summarizes matching advice to medical students looking to become future #IRads! https://t.co/ouCbZaEs31

Now Published: The ACCLAIM Trial for Liver Metastasis Ablation protocol. This study tests whether real-time 3D confirmation of a >5mm ablative margin during microwave ablation ensures local control of colorectal liver metastases ≤2.5 cm. Read More: https://t.co/HfrFtK0lGf

Excited to share our new article in IR Quarterly: How to Match We highlight tips for students pursuing Interventional Radiology, including mentorship, away rotations, and building a strong application. #InterventionalRadiology #ResidencyMatch https://t.co/OYtbwMatao

@oncodaily

Big thanks to: @KelseyLauMin @ChrisManzMD @onctom and @DanaFarber/@DFCIPopSci for the support on this project

This work highlights that #disparities in #cancer outcomes are complex. Novel therapies improve survival overall, but race/ethnicity remain strong predictors — underscoring the need for #equity-focused research & care strategies.

Implications: ➡️ Asian & Hispanic patients experienced better survival with systemic therapy for HCC. ➡️ Survival differences were not fully explained by treatment patterns or clinical/social factors. ➡️ More work is needed to understand why

Receipt of novel therapy improved OS by 37% overall — but survival advantages for Asian & Hispanic patients persisted even after adjusting for treatment, liver function, and #socioeconomic factors.

In adjusted models: Asian patients had 21% lower risk of death (HR 0.79) Hispanic patients had 28% lower risk of death (HR 0.72) Black patients had similar OS to White patients

Survival outcomes: 📈 Median overall #survival (OS) Asian: 10.3 months Hispanic: 10.5 months White: 8.0 months Non-Hispanic: 8.3 months

Treatment patterns: - Asian patients were 78% more likely than White patients to receive novel systemic therapies. - No significant differences in receipt of novel therapy for Black or Hispanic patients compared with White patients.

Using the @flatironhealth Health database (2011–2023), we analyzed 4,198 patients with HCC: 53% White, 12% Black, 5% Asian, 11% Hispanic.

Background: #HCC incidence has been rising and disproportionately affects Black, Asian, and Hispanic patients. Until recently, systemic therapy options were limited (mainly sorafenib). Between 2017–2022, 9 new therapies were approved, changing the treatment landscape.

Presented at #ESCCongress: In patients with cardiovascular disease and an implantable cardioverter–defibrillator, increasing potassium levels to the high-normal range reduced the risk of arrhythmia events, hospitalizations, and death. Full POTCAST trial results:

Check out our review article that was Editor's Choices in this month's issue of #JACR with @amykpatel, @EJFloresMD, @TomaOmofoyeMD, @MeghaGargMD, @RMilesMD https://t.co/iFsEAfSSZf

⚡The Role of Radiology in Community Engagement​ 🚨Radiologists: your expertise can do more than diagnose—engage with your community, break down barriers to care, and make a real impact on health equity! Read on to learn more.​ 🔗 https://t.co/I2w3Sp7Nqr ​@cookyscan1 @RadG_Editor

All hospital rooms should have a window with direct access to sunlight.

If you were making a list of the costs or drawbacks to cell phone bans in schools, what would you include?